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INTERrEd-4 (IL-4) and interleukin-lO OL-lO)
were evaluated for their ability to inhibit the pro-
duction of nitric oxide (NO) by interferon-T (IFN-
7)- or lipopolysaccharide (LPS)-activated murine
macrophages (RAW 264.7 and J774.2). Macro-
phages pre-treated with IL-4 and then stimulated
with IFN-T or LPS showed significant inhibition
in their ability to produce NO as measured by
nitrite production. Simultaneous treatment of IL-4
pre-incubated cells with IFN-T and LPS together
augmented nitrite accumulation. On the other
hand, similar exposures of the macrophages to
IL-IO followed by IFN-T or LPS treatments resulted
in significantly increased NO production. Thus IL-
l0 failed to suppress IFN-T or LPS-induced NO
production and showed opposite effects in these
experiments to IL-4. We conclude that the two
lymphokines have differing roles in the control
of production of NO and might act to control the
secretion of nitric oxide in vivo.
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Introduction
Murine macrophage cell lines or peritoneal
macrophages express high levels of inducible
nitric oxide synthase (iNOS) and secrete large
amounts of nitric oxide (NO) when activated
with lipopolysaccharide (LPS) or cytokines.- Macrophage activation for the expression of
iNOS and production of NO is a multisignal and
multistep process and involves the L-arginine:NO
pathway, where NO is synthesized from the gua-
nidino nitrogen of L-arginine by the enzyme
iNOS.4-7
A few purified cytokines are known to sup-
press macrophage nitric oxide induction in vitro.
Transforming growth factor-J3 (TGF-[3) and
macrophage deactivation factor (MDF) are two
previously described agents affecting lymphocyte
function. Interleukin 10 (IL-10) and interleukin 4
(IL-4), secretory products of Th2 helper T lym-
phocytes (Th2 cells) are cytokines whose biologi-
cal actions antagonize IFNq, secreting Thl helper
T lymphocytes (Thl cells).
8 The antagonistic
effect of the two groups of cells is cross-modula-
tory in action and is thought to be a mechanism
that plays a role in homeostasis.
According to a number of investigators, the
treatment of macrophages by IL-10 and IL-4 sup-
presses the induction and production of TNF-cz,
reactive oxygen intermediates (ROI) and reactive
nitrogen intermediates (RNI) that are antimicro-
bial and tumoricidal in action.9- In this respect,
Thl secretory products are thought to play a role
in host-defence whereas Th2 cells are disease-
promoting.
12
The purpose of the present study was to
compare and contrast the in vitro IL-4 and IL-10
macrophage deactivation and inhibition of NO
secretion in IFNq,- and LPS- activated macro-
phage-like murine cell lines.
Materials and Methods
Cytokines and biochemicals: Recombinant
murine IFN-T, IL-10 and IL-4 were purchased
from Genzyme Diagnostics, Kent, UK. Lipopoly-
saccharide from E. coli O:111 B4, sulphanilamide,
sodium nitrite, and N-(1-naphthyl)-ethylenedi-
amine dihydrochloride were purchased from
Sigma Chemical Co. Ltd, Poole, UK. Orthophos-
phoric acid was purchased from BDH Chem. Co.
Ltd, Poole, UK. Foetal calf serum, L-glutamine
and RPMI 1640 medium were purchased from
Gibco (Life Technologies) Ltd, Paisley, UK.
Cells and cell cultures: Macrophage-like murine
cell lines (RAW 264.7 and J774.2) were obtained
from the European Collection of Animal Cell
Cultures, Salisbury, Wiltshire, UK. The macro-
phages were cultured in RPMI 1640 medium sup-
plemented with foetal calf serum (5%), L-
glutamine (2mM), streptomycin (100g/ml) and
penicillin (100U/ml) for 3-4 days. Prior to
experiments, the cells were washed and resus-
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pended in flesh medium and their number
adjusted to 2 x 106/ml medium. The cells were
then plated into 96-well microtitre plates (5 x
105 cells/well in a volume of 250 I.tl) in triplicate
and incubated for 2 h at 37C in a 5% CO2 atmo-
sphere to allow them to adhere. The supernatant
was removed by aspiration and the cell mono-
layers were washed twice to remove non-adher-
ent cells. Cell viability was always greater than
90% as determined by the trypan blue dye exclu-
sion criterion.
Addition of cytokines and lipopolysaccharide:
The washed cell monolayers were treated with
IL-10 (100U/ml) or IL-4 (100U/ml) and incu-
bated for 20h prior to the addition of murine
IFN-7 or LPS. Dose-response experiments and
our previous work and our unpublished obser-
vations showed that 50-100 U/ml of IL-4 and
IL-10 was a minimum concentration to produce
maximal effects in the current assays. Thus a
concentration of 100 U/ml was used for these
cytokines throughout. After incubation, the
supernatant was aspirated and the cell mono-
layers were washed twice with medium. The cells
were then re-exposed to the same concentra-
tions of IL-4 and IL-10 in the presence of IFN-T
(100 W/ml) and/or LPS (100 ng/ml) for NO pro-
duction. Cells were also treated with either IL-4,
IL-10, IFN-T or LPS alone for 20h to act as con-
trois.
Nitrite assay.. After 20h of incubation, the pre-
sence of nitrite in the culture medium as an indi-
cation of NO production was determined by the
Griess reaction as described previously.
4 Briefly,
supernatant (100 l.tl) from each well was mixed
with an equal volume of Griess reagent [1 part
of 0.1% N-(1-naphthyl)-ethylenediamine dihy-
drochloride in distilled water plus 1 part of 1%
sulphanilamide in 5% concentrated phosphoric
acid] in a 96-well microtitre plate and incubated
at room temperature in the dark for 10-20 min.
The optical density of the chromogen was mea-
sured at 540nm with a microtitre plate reader
(Titertek multiscan). Nitrite concentration in the
supernatant was determined in nanomoles from
a standard curve generated with sodium nitrite
ranging from 1 to 200 nmol.
Calculation and statistical analysis.. Nitrite con-
centrations for each cell group were calculated
from the standard curve and data are expressed
as nmol of nitrite per 5 x 105 cells. All values
represent the mean and standard error (S.E..) of
three separate experiments performed in tripli-
cate. Statistical analysis was performed with the
Student t-test, using Minitab Release 8.2 software.
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FIG. 1. Effect of IL-4 (100 U/ml) pre-treatment on IFN-T (IFN)-
(100 U/ml) or LPS-(100 ng/ml) stimulated nitric oxide produc-
tion in RAW 264.7 macrophages. Results shown are mean ___
S.E. for three separate experiments performed in triplicate.
Results
When RAW 264.7 macrophages were activated
with either murine IFN-T or LPS, or IFN-T plus
LPS, high levels of nitrite were measured in the
culture supernatants assayed. Pre-incubation of
the same macrophages with IL-4 for 20h and
treating them with either IFN-T or LPS inhibited
NO production (Fig. 1). Inhibition difference was
observed to be highly significant between results
of IFN-7 plus IL-4 and IFN-T alone (p < 0.001)
and LPS plus IL-4 and LPS only (p < 0.01).
Treatment of macrophages with IL-4 only for
20h or more failed to induce NO production
when compared with the controls (untreated
cells). Furthermore, simultaneous treatment of IL-
4 pre-treated cells with IFN-7 in the presence of
LPS could not inhibit the production of NO (Fig.
1). This result suggests that IL-4 is able to inhibit
or block either LPS or IFN-T-induced NO produc-
tion but is unable to overcome the combined
effect of these stimuli. The same pattern of
results was recorded when a different cell line
0774.2) was used (data not shown).
On the other hand, when the RAW 264.7 cells
were pre-incubated with IL-10 for 20h and then
stimulated with either IFN-T or LPS or with both
agents, there was no inhibition of nitrite produc-
tion compared with controls (Fig. 2). Indeed, IL-
10 pre-treatment was found to significantly
increase the production of nitric oxide in cells
stimulated with IFN-T (p < 0.01) or LPS (p <
0.05). Besides, even at higher concentrations
(500 U/ml) or increased or decreased incubation
times, IL-10 was not capable of suppressing NO
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FIG. 2. Effect of pre-treatment of macrophages (RAW 264.7)
with IL-10 (100 U/ml) on IFN-y (100 U/ml) or LPS-(100 ng/ml)
induced nitric oxide production. Data are mean ___
S.E. for three
separate experiments performed in triplicate.
production (results not shown). Furthermore,
Fig. 2 shows that IL-10 in the absence of IFN-2
or LPS had no effect on the induction of NO in
the macrophages used. Interleukin-10 was found
to have the same nitric oxide potentiating effects
in J774.2 cell lines (data not shown).
Discussion
This study demonstrates the clear differences
between the actions of the Th2 lymphokines, IL-
10 and IL-4 on the LPS- or IFN-7-stimulated pro-
duction of nitric oxide in murine macrophages.
The suppression of nitric oxide synthesis by pre-
incubation of the cells with IL-4 is in aRreement
with the work of other investigators.8’’’
According to Bogdan and colleagues,
7 IL-10
was found to be a weak inhibitor of reactive
nitrogen intermediates production in activated
macrophages. Contrary to the observation of a
number of other investigators,
9-12 IL-10 failed to
inhibit IFN-3,- or LPS-induced NO production in
both murine macrophage cell lines examined in
this work. Moreover, in this study we found that
IL-10 could enhance the LPS- or IFN-2-stimulated
production of nitric oxide. In this respect our
results are in agreement with the work of other
1819 r rt th investigators who also epo ed a IL-10
could enhance nitric oxide production.
Recently, it has been suggested that at least
some of the effects of lymphokines on macro-
phages may be mediated via changes in lipid
metabolism. In this regard, it was found that IL-
4, IL-10 and IFNq, had different effects on macro-
phage fatty acid metabolism, and this was corre-
lated with different effects on TNF-z and nitric
oxide production.
2
In conclusion, although the two subsets of lym-
phocytes (Thl and TH2), with distinct biological
functions, are known to have antagonistic roles,
our data demonstrate that Th2 cytokine products
(IL-4 and IL-10) have different effects on IFN-q,-or
LPS-induced NO production in macrophages. It is
possible that these lymphokines regulate the pro-
duction ofNO in vivo so that maximal bactericidal
and minimal host tissue destruction are elicited.
The molecular basis for the differing roles of lym-
phokines in the control of NO production is cur-
rently under investigation in our laboratory.
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